Domestic first-in-class drug approvals

根据国家药监局数据，2025年76个审批的创新药中，有11个是首创新药，但其中仅有4个是国内本土研发。

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA

Ministry of Commerce of China. (2025). 2025年我国批准创新药76个 对外授权超千亿美元. Retrieved September 17, 2026, from https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Via StatOrigin, https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN

Copy

MLA

Ministry of Commerce of China. "2025年我国批准创新药76个 对外授权超千亿美元." 2025, https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN.

Copy

Chicago

Ministry of Commerce of China. "2025年我国批准创新药76个 对外授权超千亿美元." 2025. https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN.

Copy

BibTeX

@misc{mofcom2025domesticay01yn, author = {{Ministry of Commerce of China}}, title = {2025年我国批准创新药76个 对外授权超千亿美元}, year = {2025}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN}, note = {Original source: https://tradeinservices.mofcom.gov.cn/article/hyly/zyy/zyyfwbmdt/202601/180991.html. Accessed September 17, 2026.} }

Copy

Everything needed to check this number yourself, without taking our word for it.

Record last modified 17 September 2026. Value type: actual. Update cadence: annual. This page is permanently addressable at statorigin.org/stat/stat_H0A44FGGE45T9X6BB14NAY01YN.